23 FDA COMMITTEE VOTES FOR PAXLOVID 16 TO 1 (www.drugstorenews.com) posted 1 year ago by Kingslea 1 year ago by Kingslea +23 / -0 FDA advisory committee votes in support of Pfizer’s Paxlovid The committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid for treating mild to moderate COVID-19 in adult patients at high risk for progression to severe illness. 4 comments share 4 comments share save hide report block hide replies
Damn! I did not know that.